I've worked hard my whole life, but it wasn't until my introduction to investing where I found my groove and was able to make it big. A movie fan, collector, and big kid at heart, I can finally indulge in all the finer things in life I was denied as a child! The world is mine!
I've worked hard my whole life, but it wasn't until my introduction to investing where I found my groove and was able to make it big. A movie fan, collector, and big kid at heart, I can finally indulge in all the finer things in life I was denied as a child! The world is mine!
less
Latest Comments
Joe Biden And Benjamin Netanyahu Will Be Welcomed At The Gates Of Hell
Well said.
Google's War With The News Threatens To Spread To The U.S.
Really interesting, thanks.
The Bare Minimum
Maybe not. But places like Iran and Russia can determine if there is world peace or not. Both regularly try to destabalize other countries.
How Much Longer Must This Go On?
What do you mean if this were 1945 the warring would be over? WWII lasted 6 years! And we're far from a world war. Just Ukraine/Russia and Israel/Hamas.
AI Stock Picker
Is this your own opinion or are they compensating your for this post?
Chart Of The Week: Residential Housing Construction
$OPEN gets a large percentage of its revenues from customers that are moving out of an older or existing home and want to buy from a Builder. More Builder sales = more revenues and profits for OPENDOOR Technologies. Bullish
Can Intel And AMD Compete With Nvidia?
Better question is: Can Nvidia exist without Taiwan?
Be A Smart Investor – Don’t Hold On For Dear Life
The success of CER-1236 "eliminated leukemic cells"
Pfizer should buy CERO for $500
"The results found the target for CER-1236 is found in the large majority (83%) of leukemic cells extracted from the bone marrow from patients, and that more importantly CER-1236 effectively eliminated leukemic cells in the company’s experiments." -first paragraph:
CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients
GlycoMimetics: A Potential Game Changer In Blood Cancers With Near-Term Catalysts
Looks good, thanks.
Chart Of The Day: Stellantis - Back In The Driver's Seat
$STLA looks good.